120 related articles for article (PubMed ID: 37572015)
1. Prognostic significance of 25-hydroxyvitamin D levels in patients with peripheral T-cell lymphoma.
Park YG; Cho H; Kim S; Lee K; Ryu JS; Chae EJ; Kim KW; Park CS; Go H; Lee SW; Lee YS; Kwon M; Kim CW; Yoon DH
Leuk Lymphoma; 2023 Dec; 64(12):1949-1955. PubMed ID: 37572015
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D deficiency is associated with inferior survival of patients with extranodal natural killer/T-cell lymphoma.
Kim SJ; Shu C; Ryu KJ; Kang D; Cho J; Ko YH; Lee SY; Guallar E; Zhao W; Kim WS
Cancer Sci; 2018 Dec; 109(12):3971-3980. PubMed ID: 30343526
[TBL] [Abstract][Full Text] [Related]
3. 25-Hydroxy vitamin D deficiency is an inferior predictor of peripheral T-cell lymphomas.
Shen HR; Tang J; Li WY; Liang JH; Li Y; Wu JZ; Wang L; Li JY; Gao R; Yin H; Xu W
Ann Hematol; 2024 Feb; 103(2):565-574. PubMed ID: 37951853
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.
Drake MT; Maurer MJ; Link BK; Habermann TM; Ansell SM; Micallef IN; Kelly JL; Macon WR; Nowakowski GS; Inwards DJ; Johnston PB; Singh RJ; Allmer C; Slager SL; Weiner GJ; Witzig TE; Cerhan JR
J Clin Oncol; 2010 Sep; 28(27):4191-8. PubMed ID: 20713849
[TBL] [Abstract][Full Text] [Related]
5. Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.
Abramson JS; Feldman T; Kroll-Desrosiers AR; Muffly LS; Winer E; Flowers CR; Lansigan F; Nabhan C; Nastoupil LJ; Nath R; Goy A; Castillo JJ; Jagadeesh D; Woda B; Rosen ST; Smith SM; Evens AM
Ann Oncol; 2014 Nov; 25(11):2211-2217. PubMed ID: 25193992
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of 25-hydroxy vitamin D in extranodal NK/T cell lymphoma.
Mao J; Yin H; Wang L; Wu JZ; Xia Y; Zhu HY; Fan L; Li JY; Liang JH; Xu W
Ann Hematol; 2021 Feb; 100(2):445-453. PubMed ID: 33140135
[TBL] [Abstract][Full Text] [Related]
7. 25-Hydroxy vitamin D deficiency predicts inferior prognosis in mantle cell lymphoma.
Xu DM; Liang JH; Wang L; Zhu HY; Xia Y; Fan L; Li JY; Xu W
J Cancer Res Clin Oncol; 2020 Apr; 146(4):1003-1009. PubMed ID: 31915915
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D deficiency is associated with a poor prognosis in advanced non-small cell lung cancer patients treated with platinum-based first-line chemotherapy.
Ma K; Xu W; Wang C; Li B; Su K; Li W
Cancer Biomark; 2017; 18(3):297-303. PubMed ID: 27983538
[TBL] [Abstract][Full Text] [Related]
9. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.
Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T
Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of the prognostic and clinical value of serum 25-hydroxyvitamin D levels in previously untreated lymphoma.
Tao Y; Chen H; Zhou Y; Shi Y
Future Oncol; 2021 May; 17(14):1825-1838. PubMed ID: 33728948
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma.
Nath K; Tomas AA; Flynn J; Fein JA; Alperovich A; Anagnostou T; Batlevi CL; Dahi PB; Fingrut WB; Giralt SA; Lin RJ; Palomba ML; Peled JU; Salles G; Sauter CS; Scordo M; Fraint E; Feuer E; Shah N; Slingerland JB; Devlin S; Shah GL; Gupta G; Perales MA; Shouval R
Transplant Cell Ther; 2022 Nov; 28(11):751.e1-751.e7. PubMed ID: 35944603
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Significance of Vitamin D Deficiency in Korean Patients With Multiple Myeloma.
Kim S; Cho H; Kim M; Lee K; Kim S; Yoon DH
Clin Lymphoma Myeloma Leuk; 2024 Mar; 24(3):e112-e118. PubMed ID: 38177055
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab.
Bittenbring JT; Neumann F; Altmann B; Achenbach M; Reichrath J; Ziepert M; Geisel J; Regitz E; Held G; Pfreundschuh M
J Clin Oncol; 2014 Oct; 32(29):3242-8. PubMed ID: 25135997
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C
Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy.
Hohaus S; Tisi MC; Bellesi S; Maiolo E; Alma E; Tartaglia G; Corrente F; Cuccaro A; D'Alo' F; Basile U; Larocca LM; De Stefano V
Cancer Med; 2018 Jan; 7(1):270-281. PubMed ID: 29271084
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma.
Hong JY; Hong ME; Choi MK; Chang W; Do IG; Jo JS; Jung SH; Park S; Kim SJ; Ko YH; Kim WS
Anticancer Res; 2015 Apr; 35(4):2465-74. PubMed ID: 25862915
[TBL] [Abstract][Full Text] [Related]
17. Ukraine Data on Prognostic Factors and Treatment Outcomes in Patients with Peripheral T-Cell Lymphomas.
Skrypets T; Novosad O; Pastushenko Y; Gorbach O; Kriachok I
Klin Onkol; 2019; 32(6):436-444. PubMed ID: 31842562
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of serum β2-microglobulin levels in patients with peripheral T-cell lymphoma not otherwise specified.
Kim HD; Cho H; Sohn BS; Park CS; Huh J; Ryu JS; Lee SW; Yoon SE; Kim SJ; Ko YH; Kim WS; Suh C
Leuk Lymphoma; 2022 Jan; 63(1):124-130. PubMed ID: 34702115
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort.
de Pádua Covas Lage LA; Brito CV; Levy D; Culler HF; Freitas Couto SC; de Oliveira LBA; Nogueira Zerbini MC; Rocha V; Pereira J
Leuk Res; 2022 Mar; 114():106794. PubMed ID: 35131666
[TBL] [Abstract][Full Text] [Related]
20. Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study.
Shimony S; Horowitz N; Ribakovsky E; Rozovski U; Avigdor A; Zloto K; Berger T; Avivi I; Perry C; Abadi U; Raanani P; Gafter-Gvili A; Gurion R
Hematol Oncol; 2019 Dec; 37(5):569-577. PubMed ID: 31674027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
